The short version
- Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- What the evidence isThe human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
- What to watchShaky, sweaty spells that suggest low glucose.
How Pancragen works
Pancragen is Lys-Glu-Asp-Trp: 4 residues, formula C26H36N6O9, average mass 576.61 Da. It is the most chemically distinctive molecule in the whole Khavinson catalog and nobody writing about it says why, so here are the two features that matter.
It contains the only tryptophan in the set. Tryptophan absorbs ultraviolet light at 280 nm, which means this peptide — unlike Epitalon, Bronchogen, Cardiogen or any of the purely aliphatic and acidic members — can be quantified on a standard reverse-phase HPLC run with a UV detector, with no derivatization and no mass spectrometer. That is a practical fact with a buying consequence and it appears on no vendor page.
- Injectable
On the goal map: Endocrine & reproductive (Organ-specific bioregulation)
Research on Pancragen5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
The human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
Correlative data
Sold for pancreatic function and carbohydrate metabolism, and used by people targeting glucose control. This is the arm where self-testing is easiest and most worth doing — fasting glucose and HbA1c are cheap and objective.
How the mechanism reads
Lys-Glu-Asp-Trp — a defined tetrapeptide targeting pancreatic tissue, proposed to support beta-cell function.
MechanisticThe shared claim across the Khavinson series: peptides this short are proposed to enter the cell nucleus and bind promoter regions of DNA, shifting tissue-specific gene expression.
MechanisticIf the mechanism is real anywhere, this is where it would be provable. A twelve-week HbA1c comparison is a standard, inexpensive trial design used routinely for diabetes drugs. Its absence after decades is the strongest argument against the series as a whole.
Mechanistic
Sources
- Zakutskiĭ AN, et al. The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats. Advances in Gerontology 2006 · PMID 17152728
- Fedoreyeva LI, et al. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry (Moscow) 2011;76(11):1210–1219 · PMID 22117547
- Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021;26(22):7053 · PMID 34834147
- Goncharova ND, Ivanova LG, Oganian TÉ, Vengerin AA, Khavinson VKh. Impact of tetrapeptide pancragen on endocrine function of the pancreas in old monkeys. Advances in Gerontology 2014;27(4):662–667 · PMID 25946840
- Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International Journal of Molecular Sciences 2022;23(14):7733 · PMID 35887081
- Khavinson VK, Linkova NS, Rudskoy AI, Petukhov MG. Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters. Biomolecules 2023;13(3):552 · PMID 36979488
- Kolchina N, Khavinson V, Linkova N, Yakimov A, Baitin D, Afanasyeva A, Petukhov M. Systematic search for structural motifs of peptide binding to double-stranded DNA. Nucleic Acids Research 2019;47(20):10553–10563 · PMID 31598715
- Alsulaimani RA, Quinn TJ (independent — not the Khavinson group). The efficacy and safety of animal-derived nootropics in cognitive disorders: Systematic review and meta-analysis. Cerebral Circulation – Cognition and Behavior 2021;2:100012 · PMID 36324709
Pancragen safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Type 1 diabetes or insulin use: any change in endocrine pancreatic function can shift insulin needs.
- A history of pancreatitis or a pancreatic mass.
- Pregnancy or breastfeeding: no data.
- Under 18: pancreatic regulation signals in growing tissue are untested.
What’s expected
- No felt effect is predicted from a peptide meant to nudge pancreatic gene expression.
- A subtle shift in post-meal glucose, if the claim holds.
- Mild local reaction where it is applied.
Watch for
- Shaky, sweaty spells that suggest low glucose.
- Severe upper belly pain that bores to the back.
- Unexplained weight loss.
- Yellow eyes or pale stools.
Labs that tell you it’s working
- HbA1c (Hemoglobin A1c)
- Insulin (Fasting)
- C-Peptide, Serum
- Lipase
Pancragen is a Khavinson-school pancreatic peptide; a monkey study reported endocrine pancreas effects, so glucose and insulin labs are the test. PMID 25946840
Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Pancragen FAQ4 common questions
- Is Pancragen approved for human use?
- No. Pancragen is a research compound.
- What is Pancragen researched for?
- Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- Which labs show whether it's doing anything?
- HbA1c; Insulin; C-Peptide, Serum; Lipase: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Pancragen: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



